All Terrain Financial Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.08M | Hold |
9,550
| – | – | 0.49% | 37 |
|
|
2025
Q4 | $2.18M | Hold |
9,550
| – | – | 0.5% | 35 |
|
|
2025
Q3 | $2.21M | Hold |
9,550
| – | – | 0.55% | 30 |
|
|
2025
Q2 | $1.77M | Hold |
9,550
| – | – | 0.51% | 34 |
|
|
2025
Q1 | $2M | Sell |
9,550
-27
| -0.3% | -$5.25K | 0.63% | 30 |
|
|
2024
Q4 | $1.7M | Sell |
9,577
-1,500
| -14% | -$276K | 0.56% | 35 |
|
|
2024
Q3 | $2.19M | Hold |
11,077
| – | – | 0.8% | 27 |
|
|
2024
Q2 | $1.9M | Hold |
11,077
| – | – | 0.75% | 29 |
|
|
2024
Q1 | $2.02M | Hold |
11,077
| – | – | 0.79% | 28 |
|
|
2023
Q4 | $1.72M | Hold |
11,077
| – | – | 0.65% | 32 |
|
|
2023
Q3 | $1.65M | Sell |
11,077
-100
| -0.9% | -$14.7K | 0.69% | 32 |
|
|
2023
Q2 | $1.51M | Hold |
11,177
| – | – | 0.57% | 34 |
|
|
2023
Q1 | $1.78M | Hold |
11,177
| – | – | 0.73% | 32 |
|
|
2022
Q4 | $1.81M | Sell |
11,177
-275
| -2% | -$42.2K | 0.8% | 29 |
|
|
2022
Q3 | $1.54M | Sell |
11,452
-514
| -4% | -$73.8K | 0.66% | 30 |
|
|
2022
Q2 | $1.83M | Buy |
11,966
+4
| +0% | +$611 | 0.78% | 28 |
|
|
2022
Q1 | $1.94M | Sell |
11,962
-180
| -1% | -$26.1K | 0.78% | 30 |
|
|
2021
Q4 | $1.64M | Buy |
12,142
+6
| +0% | +$709 | 0.67% | 32 |
|
|
2021
Q3 | $1.31M | Buy |
12,136
+549
| +5% | +$62.7K | 0.57% | 34 |
|
|
2021
Q2 | $1.3M | Buy |
11,587
+85
| +0.7% | +$9.57K | 0.6% | 36 |
|
|
2021
Q1 | $1.25M | Hold |
11,502
| – | – | 0.57% | 37 |
|
|
2020
Q4 | $1.23M | Sell |
11,502
-126
| -1% | -$12.1K | 0.48% | 35 |
|
|
2020
Q3 | $1.02M | Sell |
11,628
-2,199
| -16% | -$207K | 0.35% | 44 |
|
|
2020
Q2 | $1.36M | Sell |
13,827
-628
| -4% | -$55.3K | 0.56% | 40 |
|
|
2020
Q1 | $1.1M | Sell |
14,455
-26,465
| -65% | -$2.25M | 0.45% | 47 |
|
|
2019
Q4 | $3.62M | Buy |
40,920
+1,653
| +4% | +$137K | 1.18% | 22 |
|
|
2019
Q3 | $2.96M | Buy |
39,267
+477
| +1% | +$32.7K | 0.99% | 28 |
|
|
2019
Q2 | $2.82M | Sell |
38,790
-603
| -2% | -$47.4K | 0.96% | 27 |
|
|
2019
Q1 | $3.17M | Sell |
39,393
-547
| -1% | -$44.7K | 1.1% | 19 |
|
|
2018
Q4 | $3.68M | Sell |
39,940
-1,073
| -3% | -$94.4K | 1.47% | 13 |
|
|
2018
Q3 | $3.88M | Buy |
41,013
+28,261
| +222% | +$2.68M | 1.59% | 14 |
|
|
2018
Q2 | $1.18M | Buy |
12,752
+61
| +0.5% | +$5.96K | 0.53% | 41 |
|
|
2018
Q1 | $1.2M | Buy |
12,691
+157
| +1% | +$17.2K | 0.55% | 42 |
|
|
2017
Q4 | $1.21M | Buy |
+12,534
| New | +$1.18M | 0.56% | 42 |
|
Other funds holding ABBV
VCM
VPM
All Terrain Financial Advisors's ABBV Position: Q1 2026 in Review
All Terrain Financial Advisors held its AbbVie (ABBV) position steady in Q1 2026 at 9,550 shares worth $2.08M. The position accounts for 0.49% of the portfolio, ranked #37.
All Terrain Financial Advisors first reported a position in ABBV in Q4 2017 and has held it in 34 quarters since. The position peaked at $3.88M in Q3 2018. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- All Terrain Financial Advisors held 9,550 shares of AbbVie worth $2.08M as of Q1 2026.
- All Terrain Financial Advisors left its AbbVie share count unchanged in Q1 2026.
- AbbVie made up 0.49% of All Terrain Financial Advisors's portfolio in Q1 2026, its #37 holding.
- All Terrain Financial Advisors first reported a position in AbbVie in Q4 2017 and has held it in 34 quarters since.
- All Terrain Financial Advisors's AbbVie position peaked at $3.88M in Q3 2018.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on All Terrain Financial Advisors's 13F filing for Q1 2026, filed 12 May 2026.